A detailed history of Rubric Capital Management LP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Rubric Capital Management LP holds 56,671 shares of ANIP stock, worth $3.23 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
56,671
Previous 603,800 90.61%
Holding current value
$3.23 Million
Previous $38.4 Million 91.21%
% of portfolio
0.09%
Previous 1.14%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$54.33 - $65.72 $29.7 Million - $36 Million
-547,129 Reduced 90.61%
56,671 $3.38 Million
Q2 2024

Aug 13, 2024

SELL
$58.53 - $68.82 $20.8 Million - $24.4 Million
-354,733 Reduced 37.01%
603,800 $38.4 Million
Q1 2024

May 10, 2024

SELL
$54.2 - $69.69 $9.02 Million - $11.6 Million
-166,467 Reduced 14.8%
958,533 $66.3 Million
Q4 2023

Feb 13, 2024

BUY
$48.72 - $65.43 $13.5 Million - $18.2 Million
277,989 Added 32.82%
1,125,000 $62 Million
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $7.42 Million - $10.7 Million
198,970 Added 30.7%
847,011 $45.6 Million
Q1 2023

May 12, 2023

BUY
$37.61 - $45.72 $10.2 Million - $12.4 Million
271,909 Added 72.29%
648,041 $25.7 Million
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $2.84 Million - $3.74 Million
89,086 Added 31.04%
376,132 $15.1 Million
Q3 2022

Nov 14, 2022

BUY
$29.83 - $38.01 $6.1 Million - $7.78 Million
204,602 Added 248.17%
287,046 $9.23 Million
Q2 2022

Aug 15, 2022

BUY
$23.09 - $33.46 $1.9 Million - $2.76 Million
82,444 New
82,444 $2.45 Million
Q1 2022

May 13, 2022

SELL
$26.91 - $47.15 $8.28 Million - $14.5 Million
-307,557 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $10.1 Million - $17.5 Million
307,557 New
307,557 $14.2 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $992M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.